Should residents’ access to Alzheimer’s drug be restricted?
By
Lois A. Bowers
Jan 18, 2022
You have until Feb. 10 to share your comments with CMS about its recent proposal related to Alzheimer’s drug aducanumab (Aduhelm).
Designing for dementia
By
Lois A. Bowers
Sep 25, 2017
An app that was under development when we first told you about it in June is now available to help make living environments more friendly for those with dementia.